← News
Jul 14, 2026 Regulatory
FDA Sets a September Hearing on Psychedelic Therapeutics — Comment Deadline Is This Week
The FDA confirmed a public hearing, "Considerations for Potential Future Therapeutic Use of Psychedelic Drugs," for September 14, 2026, gathering input on therapeutic use in supervised settings. The announcement itself is from mid-July, but it's news to us and the deadline to request to present is genuinely urgent: August 21, 2026, with written comments open through October 5. One more marker in a busier-than-usual year for the agency on this compound class.
Read at FDA